Concomitant Expression of CD39, CD69, and CD103 Identifies AntitumorCD8+ T Cells in Breast Cancer Implications for Adoptive Cell Therapy

肿瘤浸润淋巴细胞 离体 CD8型 白细胞介素2受体 癌症研究 细胞毒性T细胞 免疫学 过继性细胞移植 T细胞 人口 免疫系统 医学 生物 体内 体外 生物化学 生物技术 环境卫生
作者
G. Lama,G. R. Noel,Francisco Carlos López-Márquez,Faviel F. González-Galarza,Adria Imelda Prieto Hinojosa,Lydia Enith Nava‐Rivera,Karen Willard‐Gallo,Jesús Rafael Argüello Astorga
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science Publishers]
卷期号:25 (13): 1747-1757 被引量:5
标识
DOI:10.2174/1389201025666230901094219
摘要

Background: In cancer, an effective immune response involves the action of several different cell types, among which CD8 T cells play a major role as they can specifically recognize and kill cancer cells via the release of cytotoxic molecules and cytokines, being of major importance for adoptive cell transfer (ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs). The inflammation resulting from the tumor growth attracts both activated and bystander T cells. For an effective antitumor response, the T cell must express a specific group of chemokine receptors and integrins which include CD103, CD39, CD69, and CD25. These markers had already been analyzed in various cancers, not including breast cancer and their subsequent subtypes, until now. To analyze, the key receptors on ex vivo expanded tumor-infiltrating lymphocytes in luminal A and luminal B breast cancer (BC) subtypes. Materials and Methods: We were successful in expanding TILs ex vivo using a standard TIL culture condition from a cohort study of 15 primary luminal A and luminal B breast cancer patients. Furthermore, we examined the expression of CD103, CD39, CD69, and CD25 biomarkers after the expansion by flow cytometry. Results: We found that the information about the percentage of TILs obtainable after the ex vivo expansion is not associated to nor it is dependent on the heterogeneity of the TIL population before the expansion and does not differ by the molecular subtype (p>0.05). We also found that there is a major population of memory-resident antitumor CD8+CD103+CD39+ and CD8+CD103+ CD69+ TILs present in the stroma after the expansion when compared to CD4 immunosubtypes (p< 0.0001). Only the CD8+CD103+CD39+ subpopulation was related to BC subtype (0.0009). Conclusion: Evidence from our study suggests that CD8 TILs present in the stroma of luminal A and luminal B breast cancer patients can be quantified and phenotyped by flow cytometry and be further expanded ex vivo. The immuno-phenotyping of these markers may be targeted to improve the success of immunotherapeutic approaches, such as adoptive cellular therapy (ACT) in patients with BC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
tanjuan发布了新的文献求助10
刚刚
彳亍宣完成签到 ,获得积分10
2秒前
嗡嗡声完成签到 ,获得积分10
5秒前
6秒前
茄子回锅肉完成签到,获得积分10
7秒前
姚怜南完成签到,获得积分10
8秒前
忧心的藏鸟完成签到 ,获得积分10
8秒前
飞飞完成签到,获得积分10
10秒前
沐野完成签到 ,获得积分10
10秒前
科研通AI2S的应助被季末默相依采纳,获得10
12秒前
12秒前
qiuy发布了新的文献求助10
12秒前
Arctic完成签到 ,获得积分10
12秒前
Justtry完成签到,获得积分10
14秒前
英姑的应助被thchiang采纳,获得10
14秒前
15秒前
苗条的访冬完成签到 ,获得积分10
17秒前
dyy完成签到 ,获得积分10
20秒前
Heaven完成签到 ,获得积分10
20秒前
秋风的应助被qiuy采纳,获得20
21秒前
踏实的凝冬完成签到 ,获得积分10
23秒前
Prometheusss发布了新的文献求助10
24秒前
兴奋的惮完成签到,获得积分10
24秒前
999完成签到 ,获得积分10
25秒前
3kyo完成签到 ,获得积分10
28秒前
文静的惜霜完成签到,获得积分10
29秒前
atra2107完成签到 ,获得积分10
29秒前
小小吴完成签到,获得积分20
30秒前
31秒前
32秒前
聪明的二休完成签到,获得积分10
33秒前
thchiang发布了新的文献求助10
37秒前
美好时光完成签到 ,获得积分10
38秒前
Rice完成签到,获得积分10
40秒前
334niubi666完成签到 ,获得积分0
48秒前
爱听歌的碧彤完成签到,获得积分10
48秒前
不知道叫啥完成签到 ,获得积分10
50秒前
xiaoputaor完成签到 ,获得积分10
50秒前
阳佟半双完成签到,获得积分10
53秒前
Z小姐完成签到 ,获得积分10
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180084
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808758
捐赠科研通 7776098
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557454
邀请新用户注册赠送积分活动 2479012